Podcasts

© Podcasts created using Google NotebookLM.

Evaluation of the Ease of Use, Effectiveness, Safety, and Satisfaction of the SyqeAir Inhaler for Medical Cannabis Treatment Among Hospitalized Patients and Medical Staff

22/12/2024

Syqe®’s second study examined the use of the SyqeAir Inhaler for medical cannabis administration in hospitals to allow patients to maintain their treatment regimen also during hospitilizations. Listen to the podcast>>

The Pharmacokinetics, Efficacy, Safety, and Ease of Use of the SyqeAir Metered-Dose Cannabis Inhaler for Chronic Neuropathic Pain: A Phase 1a Study

12/12/2024

Syqe®’s first study examined whether metered and low doses of Δ9-THC allow for dose-dependent pain reduction of chronic neuropathic pain without significant adverse events. Listen to the podcast>>

A Low Dose of Cannabis Is More Effective Than a High Dose in Relieving Pain / ynet Editorial

20/03/2023

A clinical trial conducted by Syqe® among patients suffering from chronic pain showed that a low dose of cannabis is actually more effective in relieving pain than higher doses and causes far fewer side effects.

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

23/04/2023

Israeli startup Syqe® says it’s solved the problem of unpredictable and inconsistent medical cannabis treatment with the SyqeAir Inhaler and Cartridges that deliver the same dose of cannabis every time.

Bedrocan highlights SyqeAir’s TGA Approval in Australia

17/11/2023

An article by Bedrocan about Syqe® receiving the Therapeutic Goods Administration (TGA) approval for the SyqeAir inhaler in Australia. This significant regulatory milestone is a step forward in the global expansion of our treatment.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.